How to Lower Uric Acid Levels
Allopurinol is the first-line medication for lowering uric acid levels, starting at 100 mg daily (or 50 mg in CKD stage ≥3) with gradual titration to achieve serum urate below 6 mg/dL. 1
Pharmacological Management
First-Line Therapy
- Allopurinol:
- Start at low dose: 100 mg daily (50 mg in CKD stage ≥3) 1, 2
- Increase by 100 mg every 2-4 weeks until target serum urate level is reached 3
- Maximum dose can be 800 mg daily, even with renal impairment with proper monitoring 2
- Target serum uric acid level: <6 mg/dL (360 μmol/L) 3
- For tophaceous gout, target may be lowered to <5 mg/dL 1
Alternative Therapies
Febuxostat:
Uricosuric agents:
Pegloticase:
Prophylaxis During Initiation of Therapy
- Concomitant anti-inflammatory prophylaxis is strongly recommended when starting urate-lowering therapy 1
- Options include:
- Colchicine
- NSAIDs
- Prednisone/prednisolone
- Continue prophylaxis for 3-6 months 1
Lifestyle Modifications
Dietary Changes
- Limit alcohol consumption, especially beer and spirits 3, 4
- Avoid sugar-sweetened drinks with high-fructose corn syrup 1, 4
- Reduce consumption of purine-rich foods (meat and seafood) 4, 5
- Encourage low-fat dairy products 3, 5
- Increase consumption of fruits (especially cherries) and vegetables 4, 5
- Maintain adequate hydration (at least 2 liters daily) 1, 2
Weight Management
- Weight loss if overweight or obese 3, 4
- Regular physical exercise (aim for 30 minutes, 5 times per week) 3
- Avoid strenuous exercise that causes dehydration, as it may trigger gout attacks 4
Monitoring
- Check serum uric acid levels every 2-4 weeks during dose titration 1
- Once target is achieved, check every 6 months 1
- Monitor for signs of drug toxicity (rash, pruritis, elevated liver enzymes) 1
Special Considerations
Renal Impairment
- In patients with renal impairment, adjust allopurinol dosing:
Asymptomatic Hyperuricemia
- Pharmacological treatment is not recommended for asymptomatic hyperuricemia 1, 3
- KDIGO guidelines recommend uric acid-lowering therapy only for symptomatic hyperuricemia 1, 3
Common Pitfalls to Avoid
Starting with high doses: Always begin with low doses of urate-lowering therapy and titrate gradually to avoid triggering acute gout attacks 3, 2
Inadequate prophylaxis: Failing to provide anti-inflammatory prophylaxis when initiating urate-lowering therapy 1
Discontinuing therapy prematurely: Urate-lowering therapy should be maintained lifelong once initiated 3
Targeting excessively low uric acid levels: While <6 mg/dL is the general target, long-term maintenance of levels <3 mg/dL is not recommended 3
Neglecting comorbidities: Patients with gout often have hypertension, diabetes, and kidney disease that require concurrent management 3